Search results
3 Reasons to Buy Moderna Stock | The Motley Fool
The Motley Fool· 16 hours agoAlthough Moderna (MRNA -2.38%) is now a somewhat famous biotech, it was a relatively unknown, clinical-stage company just five years ago. Is Moderna just...
Moderna CFO sells $97,237 in stock amid performance unit vesting By Investing.com
Investing.com· 4 days agoModerna , Inc. (NASDAQ:MRNA) reported a recent transaction by Chief Financial Officer James M. Mock,...
Moderna director Noubar Afeyan sells over $2.2m in company stock By Investing.com
Investing.com· 1 day agoModerna , Inc. (NASDAQ:MRNA) Director Noubar Afeyan has recently sold a substantial number of shares...
Moderna, Inc.'s (NASDAQ:MRNA) large institutional owners must be happy as stock continues to...
Simply Wall St. via Yahoo Finance· 13 hours agoKey Insights Significantly high institutional ownership implies Moderna's stock price is sensitive...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 2 days agoModerna stock is making a turnaround after the Food and Drug Administration approved its second-ever...
Moderna, Merck shares rise as combined melanoma therapy shows improved survival rate By...
Investing.com· 5 days agoModerna (NASDAQ:MRNA) and Merck (MRK) have released new, more encouraging three-year data on their...
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Benzinga via Yahoo Finance· 1 day agoOn Friday, Moderna Inc. (NASDAQ:MRNA) announced that it has submitted an FDA application for review...
What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
Forbes· 5 days agoCancer vaccines are finally showing promise as Moderna and Merck touted promising data on an...
Is Moderna Inc. (NASDAQ:MRNA) the Top Gene Therapy Stock to Invest in Now?
Insider Monkey via Yahoo Finance· 5 days agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we...
Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine - Moderna (NASDAQ:MRNA)
Benzinga· 1 day agoManufacturing is underway and doses of Moderna's Spikevax 2024-2025 formula will be ready to ship as early as August, pending regulatory approval CAMBRIDGE, MA / ACCESSWIRE ...